Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 144-151, July 2006

Potential Advantages of Intensity-Modulated Radiation Therapy in Gynecologic Malignancies

  • Anuja Jhingran, MD

      Affiliations

    • Corresponding Author InformationReprint requests to: Anuja Jhingran. Phone: (713) 563-2347. FAX (713) 563-6940.

Division of Radiation Oncology, Unit 1202. The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

Radiation therapy (RT) plays a critical role in the management of gynecologic malignancies. Conventional RT may treat a large amount of normal tissue, which results in increased toxicities and a limitation on total dose. Intensity-modulated radiation therapy (IMRT) helps reduce the dose to normal tissue while delivering a higher dose to the tissues with microscopic or gross disease. This may have a potential benefit in the treatment of gynecologic malignancies especially in difficult cases such as grossly positive nodes, recurrent disease, and vulvar cancer. However, there is very little clinical data and very little experience with the use of IMRT in gynecologic malignancies. Therefore, before complete acceptance of IMRT in the treatment of gynecologic malignancies, large multicenter trials are needed to help develop guidelines and standards.

Keywords:  gyn malignancies , IMRT , radiation therapy , cervical cancer , endometrial cancers

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(06)00046-4

doi:10.1016/j.semradonc.2006.05.001

Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 144-151, July 2006